Gilead boosts immunology pipeline with over $2 billion buyout of Ouro Medicines
DoubleLine Capital CEO Jeffrey Gundlach said markets are stuck in a holding pattern with few assets delivering meaningful returns, as...
Trusted Editorial content, reviewed by leading industry experts and seasoned editors. Ad Disclosure A weekend controversy involving a Solana executive...
Marc Rowan, chief executive officer of Apollo Global Management LLC, during a Bloomberg Television interview in New York, US, on...
© 2025 All Rights Reserved - Global Finances Daily.